Ahmed, YA and Yates, EA and Moss, DJ and Loeven, MA and Hussain, S-A and Hohenester, E and Turnbull, JE and Powell, AK (2016) Panels of chemically-modified heparin polysaccharides and natural heparan sulfate saccharides exhibit differences in binding to Slit and Robo, as well as variation between protein binding and cellular activity. Molecular Biosystems. ISSN 1742-2051
c6mb00432f.pdf - Published Version
Available under License Creative Commons Attribution.
Heparin/ heparan sulfate (HS) glycosaminoglycans are required for Slit-Robo cellular responses. Evidence exists for interactions between each combination of Slit, Robo and heparin/HS and for formation of a ternary complex. Heparin/HS are complex mixtures displaying extensive structural diversity. The relevance of this diversity has been studied to a limited extent using a few select chemically-modified heparins as models of HS diversity. Here we extend these studies by parallel screening of structurally diverse panels of eight chemically-modified heparin polysaccharides and numerous natural HS oligosaccharide chromatographic fractions for binding to both Drosophila Slit and Robo N-terminal domains and for activation of a chick retina axon response to the Slit fragment. Both the polysaccharides and oligosaccharide fractions displayed variability in binding and cellular activity that could not be attributed solely to increasing sulfation, extending evidence for the importance of structural diversity to natural HS as well as model modified heparins. They also displayed differences in their interactions with Slit compared to Robo, with Robo preferring compounds with higher sulfation. Furthermore, the patterns of cellular activity across compounds were different to those for binding to each protein, suggesting that biological outcomes are selectively determined in a subtle manner that does not simply reflect the sum of the separate interactions of heparin/HS with Slit and Robo.
|Uncontrolled Keywords:||0601 Biochemistry And Cell Biology|
|Subjects:||Q Science > QD Chemistry|
|Divisions:||Pharmacy & Biomolecular Sciences|
|Publisher:||Royal Society of Chemistry|
|Date Deposited:||05 Aug 2016 13:28|
|Last Modified:||30 Aug 2016 09:33|
|DOI or Identification number:||10.1039/C6MB00432F|
Actions (login required)